Rezolute, Inc. (RZLT)
NASDAQ: RZLT · Real-Time Price · USD
10.42
+0.72 (7.42%)
At close: Dec 5, 2025, 4:00 PM EST
10.64
+0.22 (2.11%)
After-hours: Dec 5, 2025, 7:48 PM EST
Rezolute Employees
Rezolute had 71 employees as of June 30, 2025. The number of employees increased by 12 or 20.34% compared to the previous year.
Employees
71
Change (1Y)
12
Growth (1Y)
20.34%
Revenue / Employee
n/a
Profits / Employee
-$1,087,099
Market Cap
966.22M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
RZLT News
- 25 days ago - Rezolute, Inc. (RZLT) Discusses Clinical Progress and Market Opportunity for Ersodetug in Hyperinsulinism Transcript - Seeking Alpha
- 25 days ago - Rezolute Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 4 weeks ago - Rezolute Reports First Quarter Fiscal 2026 Financial Results and Provides Business Update - GlobeNewsWire
- 4 weeks ago - Rezolute to Host Virtual Investor Event on Ersodetug Development Program - GlobeNewsWire
- 7 weeks ago - Rezolute to Participate in Upcoming Investor Conferences - GlobeNewsWire
- 2 months ago - Rezolute Reports Fourth Quarter and Full Year Fiscal 2025 Financial Results and Provides Business Update - GlobeNewsWire
- 2 months ago - Rezolute: FDA Pivotal Trial Alignment Change Further Bolsters Ersodetug - Seeking Alpha
- 3 months ago - Rezolute, Inc. (RZLT) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference Transcript - Seeking Alpha